查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946539

2026年全球微針藥物輸送系統市場報告

Microneedle Drug Delivery Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，微針給藥系統的市場規模迅速擴張，預計將從2025年的58.6億美元成長到2026年的69.2億美元，複合年成長率達18.1%。這一成長可能歸功於經皮給藥研究的進展、患者對微創療法的偏好日益增強、疫苗接種計劃的擴大、使用微針的臨床試驗增加以及微加工技術的進步。

預計未來幾年，微針給藥系統市場將快速成長，到2030年市場規模將達到131.6億美元，複合年成長率（CAGR）為17.4%。預測期內的成長要素包括：自我護理醫療設備的日益普及、生物製藥給藥系統投資的增加、穿戴式給藥平台的擴展、對患者依從性的日益重視以及微針產品的商業化程度不斷提高。預測期內的主要趨勢包括：可溶解微針技術的日益普及、對無痛給藥方式的需求不斷成長、對疫苗給藥應用的日益重視、自我給藥系統的擴展以及對可生物分解微針的日益重視。

預計未來幾年，肥胖症的盛行率上升將推動微針給藥系統市場的成長。肥胖症是一種以體內脂肪過度堆積為特徵的疾病，會對整體健康造成不利影響。微針給藥系統因其能為患者提供便捷無痛的給藥方式，在肥胖症治療中得到越來越廣泛的應用。例如，根據英國政府機構－健康改善和消除不平等部發布的數據，2023年至2024年，英格蘭18歲及以上成年人中約有64.5%被歸類為超重或肥胖，高於2022年至2023年的64.0%。因此，肥胖症盛行率的上升正在促進微針給藥系統市場的擴張。

為了提供客戶可靠的服務，微針藥物輸送系統市場的主要企業正致力於產品創新，例如射頻微針系統。射頻微針系統是一種微創技術，它結合了微針和射頻能源，可改善藥物傳輸並促進皮膚膠原蛋白生成，從而達到治療和美容的雙重目的。例如，2023年2月，總部位於美國的醫療美容設備製造商Candela推出了Profound Matrix系統。此多功能系統包含Sublime、Sublative RF和尖端的Matrix 施用器。 Sublime和Sublative RF皆採用雙極射頻（RF）技術，可有效改善細紋和深層皺紋。同時，Matrix Pro治療頭旨在透過一系列細小的微針將短脈衝射頻能量輸送到皮膚，促進膠原蛋白再生和生成。這提高了患者的舒適度，減少了恢復時間，並改善了整體治療效果。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球微針藥物輸送系統市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 永續性、氣候技術和循環經濟
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 溶解性微針技術的應用日益廣泛
    • 無痛給藥方式的需求日益成長
    • 更加重視疫苗接種應用
    • 自我給藥系統的擴展
    • 人們對可生物分解微針的興趣日益濃厚

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心
  • 研究所
  • 診斷檢查室
  • 生命科學公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球微針給藥系統市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球微針藥物輸送系統市場規模、比較及成長率分析
  • 全球微針藥物輸送系統市場表現：規模與成長，2020-2025年
  • 全球微針藥物輸送系統市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 透過技術
  • 中空、多孔、固體及其他技術
  • 透過使用
  • 藥物傳輸、疫苗傳遞及其他應用
  • 最終用戶
  • 生命科學、實驗室、醫院、門診手術中心和其他終端用戶
  • 按類型細分：中空
  • 固體中空微針，塗層中空微針
  • 按類型細分：多孔材料
  • 多孔矽微針，水凝膠基多孔微針
  • 按類型細分：固體
  • 用於疫苗的固體微針，用於藥物輸送的固體微針
  • 按類型細分：其他技術
  • 可溶解微針，可生物分解微針

第10章 區域與國家分析

  • 全球微針藥物輸送系統市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球微針藥物輸送系統市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 微針藥物輸送系統市場：競爭格局及市場佔有率（2024年）
  • 微針藥物輸送系統市場：公司估值矩陣
  • 微針給藥系統市場：公司概況
    • Zosano Pharma Corporation
    • Nanopass Technologies
    • Raphas Co. Ltd.
    • Micron Biomedical Inc.
    • Vaxess Technologies

第37章：其他領先和創新企業

  • Debiotech, TheraJect Inc., Corium Inc., Valeritas Inc., LTS Lohmann Therapie-Systeme AG, Cutanos, Moonlight Therapeutics Inc., QuadMedicine, SNVIA Co. Ltd., NanoPass Technologies Ltd., BioSerenTach, Innoture Medical Technology Limited, AdminMed nanoBioSciences LLC, MyLife Technologies, Micropoint Technologies

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年微針藥物輸送系統市場：提供新機會的國家
  • 2030年微針藥物輸送系統市場：充滿新機會的細分市場
  • 2030年微針藥物輸送系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MMDDS01_G26Q1

Microneedle Drug Delivery Systems are sophisticated medical devices that utilize arrays of micron-sized needles to deliver drugs, vaccines, and other therapeutic agents through the skin with minimal invasiveness. They penetrate the stratum corneum without reaching deeper nerve endings, thereby minimizing pain and discomfort.

The main types of technologies used in microneedle drug delivery systems include solid microneedle technology, hollow microneedle technology, dissolved microneedle technology, and others. In the solid microneedle method, peptides are dried onto the tips of a microneedle array, utilizing a coating of potent chemicals. These solid microneedles typically measure between 250 micrometers to 700 micrometers in length and are presented in patch form, allowing for storage at room temperature. Microneedle drug delivery systems find application in drug delivery, vaccine administration, and other therapeutic uses. They are employed in various settings such as diagnostic laboratories, life sciences, research laboratories, hospitals, ambulatory surgical centers, and other medical facilities.

Tariffs are influencing the microneedle drug delivery systems market by increasing costs of imported microfabrication equipment, specialty polymers, biocompatible materials, and precision manufacturing components. Pharmaceutical and device developers in North America and Europe are most affected due to reliance on imported high-precision inputs, while Asia-Pacific faces higher export-related costs. These tariffs are increasing development and scaling expenses. However, they are also encouraging local manufacturing capabilities, regional material sourcing, and innovation in cost-effective microneedle production processes.

The microneedle drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides microneedle drug delivery systems market statistics, including microneedle drug delivery systems industry global market size, regional shares, competitors with a microneedle drug delivery systems market share, detailed microneedle drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle drug delivery systems industry. This microneedle drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microneedle drug delivery systems market size has grown rapidly in recent years. It will grow from $5.86 billion in 2025 to $6.92 billion in 2026 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to growth in transdermal drug delivery research, rising patient preference for minimally invasive therapies, expansion of vaccination programs, increased clinical trials using microneedles, advancements in microfabrication techniques.

The microneedle drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $13.16 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to increasing adoption of self-care medical devices, rising investments in biologics delivery systems, expansion of wearable drug delivery platforms, growing focus on patient compliance, increasing commercialization of microneedle products. Major trends in the forecast period include increasing adoption of dissolving microneedle technologies, rising demand for painless drug delivery methods, growing focus on vaccine delivery applications, expansion of self-administered drug systems, enhanced emphasis on biodegradable microneedles.

The rising prevalence of obesity is anticipated to drive the growth of the microneedle drug delivery systems market in the coming years. Obesity is a medical condition defined by excessive accumulation of body fat that poses adverse risks to overall health. Microneedle drug delivery systems are increasingly utilized in obesity management as they enable the convenient and painless administration of medications to patients. For example, in May 2025, data from the Office for Health Improvement and Disparities, a United Kingdom-based government body, indicated that between 2023 and 2024, approximately 64.5% of adults aged 18 years and above in England were classified as overweight or living with obesity, compared to 64.0% during 2022 to 2023. Consequently, the growing prevalence of obesity is contributing to the expansion of the microneedle drug delivery systems market.

Major companies in the microneedle drug delivery systems market are concentrating on product innovation, such as radiofrequency microneedle systems, to deliver dependable services to their customers. A radiofrequency microneedle system is a minimally invasive technology that integrates microneedles with radiofrequency energy to improve drug delivery and stimulate collagen production in the skin for both therapeutic and cosmetic purposes. For example, in February 2023, Candela, a US-based medical aesthetic device manufacturer, introduced the Profound Matrix system. This multi-application system includes the Sublime, Sublative RF, and the cutting-edge Matrix Pro applicators. Both the Sublime and Sublative RF utilize bipolar radiofrequency (RF) technology to enhance the appearance of fine lines and wrinkles, while the Matrix Pro applicator is designed to regenerate and stimulate collagen production. It features a series of slender microneedles that deliver short-pulse RF energy to the skin, resulting in improved patient comfort, decreased downtime, and enhanced overall outcomes.

In October 2023, JW Pharmaceutical Corp., a South Korea-based pharmaceutical company, entered into a partnership with Theraject Asia Co., Ltd. to support the development of microneedle-based treatments for hair loss. Through this collaboration, JW Pharmaceutical and Theraject Asia seek to utilize Theraject Asia's microneedle technology platform to develop user-friendly and effective drug delivery solutions for hair loss by integrating advanced drug formulations with next-generation transdermal delivery approaches. Theraject Asia Co., Ltd. is a South Korea-based company focused on microneedle research and drug delivery technologies.

Major companies operating in the microneedle drug delivery systems market are Zosano Pharma Corporation, Nanopass Technologies, Raphas Co. Ltd., Micron Biomedical Inc., Vaxess Technologies, Debiotech, TheraJect Inc., Corium Inc., Valeritas Inc., LTS Lohmann Therapie-Systeme AG, Cutanos, Moonlight Therapeutics Inc., QuadMedicine, SNVIA Co. Ltd., NanoPass Technologies Ltd., BioSerenTach, Innoture Medical Technology Limited, AdminMed nanoBioSciences LLC, MyLife Technologies, Micropoint Technologies

North America was the largest region in the microneedle drug delivery systems market in 2025. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the microneedle drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The microneedle drug delivery systems market consists of sales of hydrogel microneedles and dissolvable microneedle. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microneedle Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses microneedle drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microneedle drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microneedle drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Hollow; Porous; Solid; Other Technologies
  • 2) By Application: Drug Delivery; Vaccine Delivery; Other Applications
  • 3) By End-User: Life Sciences; Research Laboratories; Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Hollow: Solid Hollow Microneedles; Coated Hollow Microneedles
  • 2) By Porous: Porous Silicon Microneedles; Hydrogel-Based Porous Microneedles
  • 3) By Solid: Solid Microneedles For Vaccination; Solid Microneedles For Drug Delivery
  • 4) By Other Technologies: Dissolving Microneedles; Biodegradable Microneedles
  • Companies Mentioned: Zosano Pharma Corporation; Nanopass Technologies; Raphas Co. Ltd.; Micron Biomedical Inc.; Vaxess Technologies; Debiotech; TheraJect Inc.; Corium Inc.; Valeritas Inc.; LTS Lohmann Therapie-Systeme AG; Cutanos; Moonlight Therapeutics Inc.; QuadMedicine; SNVIA Co. Ltd.; NanoPass Technologies Ltd.; BioSerenTach; Innoture Medical Technology Limited; AdminMed nanoBioSciences LLC; MyLife Technologies; Micropoint Technologies
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Microneedle Drug Delivery Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Microneedle Drug Delivery Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Microneedle Drug Delivery Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Microneedle Drug Delivery Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Sustainability, Climate Tech & Circular Economy
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Dissolving Microneedle Technologies
    • 4.2.2 Rising Demand For Painless Drug Delivery Methods
    • 4.2.3 Growing Focus On Vaccine Delivery Applications
    • 4.2.4 Expansion Of Self-Administered Drug Systems
    • 4.2.5 Enhanced Emphasis On Biodegradable Microneedles

5. Microneedle Drug Delivery Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Research Laboratories
  • 5.4 Diagnostics Laboratories
  • 5.5 Life Sciences Companies

6. Microneedle Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Microneedle Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Microneedle Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Microneedle Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Microneedle Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Microneedle Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Microneedle Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Microneedle Drug Delivery Systems Market Segmentation

  • 9.1. Global Microneedle Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hollow, Porous, Solid, Other Technologies
  • 9.2. Global Microneedle Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Delivery, Vaccine Delivery, Other Applications
  • 9.3. Global Microneedle Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Life Sciences, Research Laboratories, Hospitals, Ambulatory Surgical Centers, Other End-Users
  • 9.4. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Hollow, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solid Hollow Microneedles, Coated Hollow Microneedles
  • 9.5. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Porous, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Porous Silicon Microneedles, Hydrogel-Based Porous Microneedles
  • 9.6. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Solid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solid Microneedles For Vaccination, Solid Microneedles For Drug Delivery
  • 9.7. Global Microneedle Drug Delivery Systems Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Dissolving Microneedles, Biodegradable Microneedles

10. Microneedle Drug Delivery Systems Market Regional And Country Analysis

  • 10.1. Global Microneedle Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Microneedle Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Microneedle Drug Delivery Systems Market

  • 11.1. Asia-Pacific Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Microneedle Drug Delivery Systems Market

  • 12.1. China Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Microneedle Drug Delivery Systems Market

  • 13.1. India Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Microneedle Drug Delivery Systems Market

  • 14.1. Japan Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Microneedle Drug Delivery Systems Market

  • 15.1. Australia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Microneedle Drug Delivery Systems Market

  • 16.1. Indonesia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Microneedle Drug Delivery Systems Market

  • 17.1. South Korea Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Microneedle Drug Delivery Systems Market

  • 18.1. Taiwan Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Microneedle Drug Delivery Systems Market

  • 19.1. South East Asia Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Microneedle Drug Delivery Systems Market

  • 20.1. Western Europe Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Microneedle Drug Delivery Systems Market

  • 21.1. UK Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Microneedle Drug Delivery Systems Market

  • 22.1. Germany Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Microneedle Drug Delivery Systems Market

  • 23.1. France Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Microneedle Drug Delivery Systems Market

  • 24.1. Italy Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Microneedle Drug Delivery Systems Market

  • 25.1. Spain Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Microneedle Drug Delivery Systems Market

  • 26.1. Eastern Europe Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Microneedle Drug Delivery Systems Market

  • 27.1. Russia Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Microneedle Drug Delivery Systems Market

  • 28.1. North America Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Microneedle Drug Delivery Systems Market

  • 29.1. USA Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Microneedle Drug Delivery Systems Market

  • 30.1. Canada Microneedle Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Microneedle Drug Delivery Systems Market

  • 31.1. South America Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Microneedle Drug Delivery Systems Market

  • 32.1. Brazil Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Microneedle Drug Delivery Systems Market

  • 33.1. Middle East Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Microneedle Drug Delivery Systems Market

  • 34.1. Africa Microneedle Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Microneedle Drug Delivery Systems Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Microneedle Drug Delivery Systems Market Regulatory and Investment Landscape

36. Microneedle Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 36.1. Microneedle Drug Delivery Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Microneedle Drug Delivery Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Microneedle Drug Delivery Systems Market Company Profiles
    • 36.3.1. Zosano Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Nanopass Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Raphas Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Micron Biomedical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Vaxess Technologies Overview, Products and Services, Strategy and Financial Analysis

37. Microneedle Drug Delivery Systems Market Other Major And Innovative Companies

  • Debiotech, TheraJect Inc., Corium Inc., Valeritas Inc., LTS Lohmann Therapie-Systeme AG, Cutanos, Moonlight Therapeutics Inc., QuadMedicine, SNVIA Co. Ltd., NanoPass Technologies Ltd., BioSerenTach, Innoture Medical Technology Limited, AdminMed nanoBioSciences LLC, MyLife Technologies, Micropoint Technologies

38. Global Microneedle Drug Delivery Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Microneedle Drug Delivery Systems Market

40. Microneedle Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Microneedle Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Microneedle Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Microneedle Drug Delivery Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer